Status:
COMPLETED
Enlighten: An Adaptive Technology Weight Loss Intervention
Lead Sponsor:
Northwestern University
Conditions:
Obesity
Weight Loss
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The Enlighten study is an 8-week trial investigating the response to use of a smartphone diet and activity application. Participants are enrolled as part of a worksite intervention, and will receive t...
Eligibility Criteria
Inclusion
- BMI greater than 25-39.9 kg/m2
- Weigh no more than 300 pounds.
- Weight stable (no loss or gain \>25 lbs for the past 6 months)
- Not enrolled in any formal weight loss program
- Not currently taking anti-obesity medications
- Interested in losing weight
- Own an Android Smartphone or iPhone, be willing to install the Lose It! Application, and agree to join the Enlighten group which will allow study staff to view participant data using a private coaching interface.
Exclusion
- Unstable medical conditions (uncontrolled hypertension, diabetes, unstable angina pectoris, myocardial infarction, transient ischemic attack, cancer undergoing active treatment, or cerebrovascular accident within the past six months)
- History of diabetes requiring insulin supplementation
- Crohn's Disease
- Diagnosis of obstructive sleep apnea requiring intervention (i.e. CPAP)
- Require use of an assistive device for mobility (e.g., wheelchair, walker, cane)
- BMI greater than or equal to 40, weight greater than or equal to 300 pounds
- Hospitalization for a psychiatric disorder within the past 5 years
- Those at risk for adverse cardiovascular (CVD) events with moderate intensity activity
- Those who cannot read the study questionnaires will be excluded
- Those currently taking weight loss medication or committed to following an incompatible dietary regimen.
- Female participants may not be pregnant, trying to get pregnant, or lactating.
- Bulimia Nervosa
- Binge Eating Disorder
- Active Suicidal Ideation
- those on medications known to cause weight gain (e.g., prednisone)
- current substance abuse or dependence besides nicotine dependence
- low motivation to change that would interfere with program adherence
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01855932
Start Date
May 1 2013
End Date
September 1 2013
Last Update
September 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611